Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Melanoma|Breast Cancer|Renal Cell Carcinoma|Urinary Bladder Cancer|Squamous Cell Carcinoma of Head and Neck|Small Cell Carcinoma|NSCLC
Interventions: OTHER: MDSC quantification
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano